Condensed Balance Sheets - USD ($)	Jun. 30, 2022	Sep. 30, 2021
Current assets
Cash and cash equivalents	$ 3,588,912	$ 5,783,994
Deferred costs	180,000	180,000
Prepaid expenses	28,187	279,832
Total current assets	3,797,099	6,243,826
Deferred costs	375,000	510,000
Total assets	4,172,099	6,753,826
Current liabilities
Accounts payable and accrued liabilities	611,723	1,462,732
Accrued compensation	175,000	25,000
Total current liabilities	786,723	1,487,732
Total liabilities	786,723	1,487,732
Commitments and contingencies
Stockholders’ equity
Common stock, $0.001 par value, 681,000,000 shares authorized; 88,445,832 and 82,927,311 shares outstanding; and 101,860,646 and 96,342,125 issued as of June 30, 2022, and September 30, 2021, respectively	101,860	96,342
Treasury stock, at cost, 13,414,814 and 13,414,814 shares as of June 30, 2022 and September 30, 2021, respectively	(590,000)	(590,000)
Additional paid-in capital	78,237,430	77,290,643
Accumulated deficit	(74,363,914)	(71,530,891)
Total stockholders’ equity	3,385,376	5,266,094
Total liabilities and stockholders’ equity	$ 4,172,099	$ 6,753,826

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.